Alexza Pharma (ALXA) Tops Q1 EPS by 49c

Alexza Pharma (NASDAQ: ALXA) reported Q1 EPS of ($0.02), $0.49 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $705 thousand versus the consensus estimate of $3.36 million.

For earnings history and earnings-related data on Alexza Pharma (ALXA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low